Latest Residues revaloration and bioremed biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Investigadores del IMIBIC desarrollan una técnica no invasiva para estudiar un tipo de alopecia autoinmune sin necesidad de biopsia

by Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)

2 months ago
alopecia areata, tape stripping

Este avance podría facilitar el seguimiento de los pacientes, especialmente en población pediátrica, y contribuir a una medicina más personalizada en alopecia areata.

Un estudio explica por qué los pacientes mayores de 70 años fueron más vulnerables a la COVID-19 en la primera ola

by CIBER - ISCIII

2 months ago
interferón gamma, granzima A, SARS-CoV-2, respuesta trombo-inflamatoria

Durante el primer año de la pandemia de COVID-19, la mortalidad afectó de forma especialmente intensa a los pacientes mayores de 70 años, en un contexto en el que todavía no se disponía de vacuna...

A new experimental strategy enables the elimination of proteins involved in pathological processes

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

2 months ago
ubiquitin, proteasome, Protacs, IMPDH2, CERT1

It has been developed a strategy that enables the forced elimination of proteins that help tumors survive chemotherapy. This finding opens a new avenue to tackle resistance to cancer treatments, one o...

Together with Patients with Duchenne, IBEC is developing a ‘heart-on-a-chip’ to halt the cardiac damage caused by the condition

by IBEC - Institut de Bioenginyeria de Catalunya

2 months ago
Duchenne muscular dystrophy (DMD), ‘heart-on-a-chip’, dystrophin, BEAT Project

Duchenne Parent Project Spain has invested €247,000 in the BEAT project, which will be carried out by IBEC. Cardiomyopathy is the leading cause of death in patients with Duchenne muscular dystrophy...

An international study validates two of the leading cardiovascular risk prediction tools in more than 6.4 million people

by IRB Lleida. Institut de Recerca Biomèdica

2 months ago
PREVENT, SCORE2, cardiovascular disease, Chronic kidney disease, albumin

Research published this week in Nature Medicine confirms the global utility of the PREVENT and SCORE2 algorithms for improving cardiovascular prevention and is and suggests they should be incorporated...

A combination of treatments improves recovery after severe stroke

by Fundació Clínic per a la Recerca Biomèdica

2 months ago
thrombolytic drug, severe ischemic stroke, mechanical thrombectomy

A study coordinated by Clínic‑IDIBAPS and published in JAMA demonstrates that adding a pharmacological treatment to thrombectomy improves functional recovery in patients with severe ischemic stroke...

Researchers identify one of the mechanisms that may regulate allergen tolerance

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

2 months ago
immunoglobulin D (IgD), memory B cells, nasopharyngeal mucosa

An international collaborative study, published in the Journal of Experimental Medicine, highlights the role of immunoglobulin D (IgD) in the processes involved in generating tolerance to antigens and...

A new study discovers that the microRNA miR122 plays a key and dual role in liver regeneration

by Fundació Clínic per a la Recerca Biomèdica

2 months ago
microRNA miR122, liver regeneration, partial hepatectomy

The results show that while inhibition of miR122 accelerates regeneration in a healthy liver, its absence in a liver with fibrosis causes pathological regeneration leading to liver failure.

Analizados los factores que influyen en la respuesta emocional ante un resultado alterado en el cribado del cáncer de cérvix

by Biodonostia

2 months ago
cáncer de cérvix, escala, STAI-T

La conclusión principal es que el tipo de personalidad basal es el determinante más importante del impacto emocional tras un resultado alterado en el cribado de cérvix. Otros factores que también ...

La Unión Europea destina 1,3 millones al proyecto REACH para reducir la resistencia a la quimioterapia de uno de los tumores de páncreas más agresivos

by Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)

2 months ago
adenocarcinoma ductal pancreático (PDAC), N6-metiladenosina (m6A)

Un proyecto multicéntrico europeo que ha obtenido 1,3 millones de euros de financiación para avanzar frente al adenocarcinoma ductal pancreático (PDAC), uno de los cánceres de páncreas más agres...

Decoding cancer cell communication to improve pancreatic cancer treatment

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

2 months ago
CancerScan, pancreatic cancer, extracellular vesicles (EVs)

Cancer cells do not act alone. Through complex communication networks and signalling pathways, tumour cells and their microenvironment coordinate adaptive responses that drive drug resistance. Underst...

Sarcopenia identified as a risk factor for chemotherapy-associated neuropathy in cancer patients

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

2 months ago
sarcopenia, peripheral neuropathy, chemotherapy

According to the results, cancer patients with lower muscle mass are 2.5 times more likely to develop peripheral nerve damage because of chemotherapy.